Amend revised Phase IV CT protocol: CDSCO panel tells GSK on Respiratory Drug Combination Dr. Divya Colin3 Jan 2023 5:45 PM ISTNew Delhi: In response to the GSK's revised Phase IV clinical trial protocol for the pulmonary fixed dose combination (FDC) drug, Fluticasone...
Ajanta Pharma gets CDSCO Panel nod to study Tadalafil Oral Jelly for erectile dysfunction Dr. Divya Colin3 Jan 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
Granules India, Greenko ZeroC ink pact to enable carbon free energy, green molecule solutions Ruchika Sharma3 Jan 2023 1:00 PM ISTThis collaboration allows utilization of Fungible Carbon Offset instruments across Granules global manufacturing locations.
BDR Pharma launches generic APALUTAMIDE to treat Prostate cancer in India Ruchika Sharma3 Jan 2023 12:00 PM ISTApalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality...
Hikma Pharma unveils authorized generic of Xyrem in US Ruchika Sharma3 Jan 2023 11:00 AM ISTLondon: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has announced it has launched an authorized generic version of Jazz...
Submit Phase IV CT protocol for Entrectinib: CDSCO panel tells Roche India Dr. Divya Colin2 Jan 2023 5:45 PM ISTNew Delhi: Rejecting the drug major Roche's alternative proposal to the Phase IV clinical trial of anti-cancer Entrectinib capsules of 100 mg and 200...
Zydus Gets CDSCO panel Nod for BE Study Of Antineoplastic Drug Relugolix Dr. Divya Colin2 Jan 2023 5:30 PM ISTNew Delhi: In response to the drug major Zydus proposal for manufacture and market of anticancer drug Relugolix Tablets 120mg along with...
Centre plans to increase number of Janaushadhi Kendras to 10,000 by March 2024 Ruchika Sharma2 Jan 2023 1:12 PM ISTUnder PMBJP, an incentive of Rs 5 lakh is provided to the Janaushadhi Kendras as financial assistance.
India monitoring pharma exports to China amid COVID surge: Source Ruchika Sharma2 Jan 2023 12:12 PM ISTBengaluru: India's Ministry of Commerce has been asked to monitor exports of medicinal products and equipment to China to ensure domestic availability...
Lumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for commercial production of Lumpi-ProVac Ruchika Sharma2 Jan 2023 11:35 AM ISTLumpi-ProVac is used for the prophylactic immunization of animals against lumpy skin disease which gives protection for about one year.
Pure & Cure Healthcare secures CDSCO Panel nod for Phase 4 CT of Ivabradine,Metoprolol Tartrate FDC Dr. Divya Colin1 Jan 2023 5:00 PM ISTNew Delhi: Pure & Cure has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
USFDA grants appeal for Ardelyx XPHOZAH Ruchika Sharma1 Jan 2023 3:30 PM ISTXPHOZAH (tenapanor), discovered and developed by Ardelyx, is an investigational first-in-class phosphate absorption inhibitor (PAI).
